(Drug Name) (Drug Form) (Drug Strength)
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

VITEKTA: Oral tablet (85mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

ELVITEGRAVIR (el vye TEG ra veer) is an antiretroviral medicine. It is used to treat HIV. This medicine is not a cure for HIV. It will not stop the spread of HIV to others.

In-Depth Information

Vitekta 85mg Tablet

NDC: 619581301
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Human Immunodeficiency Virus (HIV) Infection

Storage Information
Dispense in original container or USP equivalent tight container
Store below 86 degrees F
Vitekta 85mg Tablet

Reported Side Effects for Vitekta 85mg Tablet

Depression Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Tired Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Thoughts Of Suicide Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Vomiting Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
2.0-3.0%*
Severity: MODERATE
Onset: DELAYED
Headache Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Low White Blood Cells Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Increased Blood Sugar Incidence:
5.0%*
Severity: MODERATE
Onset: DELAYED
High Triglycerides Incidence:
5.0%*
Severity: MODERATE
Onset: DELAYED
High Cholesterol Incidence:
5.0%*
Severity: MODERATE
Onset: DELAYED
Blood In The Urine Incidence:
6.0%*
Severity: MODERATE
Onset: DELAYED
High Amylase Levels Incidence:
6.0%*
Severity: MODERATE
Onset: DELAYED
High Bilirubin Level Incidence:
6.0%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
7.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Vitekta 85mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Alcohol and Vitekta 85mg Tablet(Elvitegravir)
Alcohol and Elvitegravir(Elvitegravir)
Do not take these drugs together without approval from your prescriber. Taking these drugs together may decrease the effectiveness of your HIV medicines. Notify your health care provider if you notice your medicines not working as well of you.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with VITEKTA

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5